Ebola drug maker Chimerix's stock tumbles after Dallas patient dies | WHAT REALLY HAPPENED

Ebola drug maker Chimerix's stock tumbles after Dallas patient dies

Shares of Chimerix Inc., the maker of an experimental drug to combat Ebola, sank Wednesday after the death in Dallas of a patient with the disease who received the medicine.

About two hours after officials announced the death of Thomas Eric Duncan, the Durham, N.C., company’s stock was trading at $30.54, down $2.69, or 8.1%. The shares had hit an all-time high earlier in the day before the announcement.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA